Prostate cancer
Prostate cancer is the most common cancer in men in the UK, with more than 34,000 cases diagnosed every year.
A man’s risk of getting prostate cancer increases with age. The cancer is rare in men under 50 but by the age of 80, more than half of all men have cancerous changes in their prostate. But prostate cancer often grows very slowly, meaning that many men may never know they have the disease and will die of unrelated causes.
Having one or more close relatives with prostate cancer increases the risk. And West African men and black men from the Carribean have an increased risk of prostate cancer.
Cancer Research UK is funding research into all aspects of prostate cancer including new ways to prevent, diagnose and treat the disease. For example, we are currently funding research looking at ways to screen for prostate cancer, which could help to prevent the disease.
Browse content about Prostate cancer
- December 2006 podcast transcript
- Dr Joan Austoker
- Dr Ros Eeles
- Our progress and achievements in the 1990s
- Prof David Neal
- Prof Doug Easton
- Prof Freddie Hamdy
- Prof Gareth Williams
- Prof Glyn Elwyn
- Prof Nick James
- Prostate cancer - UK incidence statistics
- Prostate cancer - UK mortality statistics
- Prostate cancer - molecular biology and genetics
- Prostate cancer - risk factors
- Prostate cancer - survival statistics
- Prostate cancer - symptoms and treatment
- Prostate cancer research
- Prostate cancer screening
- Prostate cancer statistics - Key Facts
Browse news and press releases about Prostate cancer
- "Strong correlation" between obesity and death from prostate cancer
- 'Defence' gene reveals how oestrogen fuels cancer
- Agressive prostate cancer test hope
- Beer compound could be effective against prostate cancer say scientists
- Blocking gene opens avenues for treating prostate cancer
- Broccoli linked to decreased risk of advanced prostate cancer
- Cancer Research UK urges caution over dismissal of protective effects of vitamins
- Combination prostate treatment 74% successful says study
- Diet rich in fish may reduce the spread of prostate cancer
- Early-stage testing credits pomegranate juice with cancer benefits
- Experimental treatment shows promise in small prostate cancer trial
- Fat capsules carry markers for deadly prostate cancer
- Gene 'fusions' trigger prostate cancer
- Long way to go on chilli cancer-therapy, says Cancer Research UK
- More research needed into cholesterol prostate cancer link
- NICE approves new prostate cancer treatment
- New studies examine effect of PSA screening on prostate cancer death rates
- New type of stem cell found in prostate
- Obesity linked to more aggressive prostate cancer
- Oestrogen signalling pathways are important in about half of all prostate cancers
- Omega-6 fatty acids may boost tumour growth, say researchers
- Possible lung cancer test 'has potential' says Cancer Research UK
- Prostate cancer deaths double in men with BRCA2
- Prostate cancer screening trial raises concerns about 'false positive' results
- Questions raised over prostate cancer treatment
- Scientists closer to identifying prostate cancer genes
- Scientists develop prostate cancer predictions
- Scientists find potential signal of aggressive prostate cancer
- Scientists in major prostate cancer gene discovery
- Shift rotation cancer link remains unproven says Cancer Research UK
- Smoking hampers prostate cancer treatment says research
- Study finds evidence of virus in human prostate cancer cells
- Study identifies prostate cancer genetic marker
- Survey uncovers lack of knowledge about prostate cancer
- Trial to find the best treatment for prostate cancer
- 'Breast cancer' gene linked to prostate cancer
- 'Sunshine' pill could treat prostate cancer says maker
- Alcohol cancer risks "underestimated" say researchers
- Black men face higher prostate cancer risk
- Broccoli and tomato cancer impact "unclear"
- Call for better use of prostate cancer biopsies
- Cannabis chemicals stop prostate cancer growth
- Daughters linked to prostate cancer
- Doctors develop prostate guidance site
- Experimental drug causes cell death in prostate cancer
- Extra screening does not improve diagnosis of aggressive prostate cancer
- GPs receive new guidelines for prostate cancer risk management
- Hormone therapy for prostate cancer raises heart risk
- Making sense of the PSA test for prostate cancer
- More research needed into effect of oily fish on prostate risk
- New drug shows promise against aggressive prostate cancer in small trial
- New study targets men at high risk of prostate cancer
- Newcastle scientist tells Minister of new cancer hope
- Oestrogen regulation may reverse prostate cancer says study
- Omega-3 diet may slow prostate cancer growth
- PSA prostate cancer test may be less effective in obese men
- Prompt treatment or "watchful waiting" for prostate cancer?
- Prostate cancer patients 'should remain active'
- Prostate screening may have benefits
- Researchers find signposts to prostate cancer
- Scientists develop new drug to outflank cancer resistance
- Scientists find gene clue to prostate cancer
- Scientists identify new prostate cancer risk factor
- Seven new prostate cancer genetic risk factors identified
- Small study suggests vitamin D may lower PSA levels in some prostate cancer patients
- Sound waves treat prostate cancer with fewer side effects
- Study identifies new prostate cancer indicator
- Study links frequent multivitamin use and advanced prostate cancer
- Tests of satraplatin for prostate cancer show encouraging results
- World experts call for Scotland to act against prostate cancer
Increase text
Decrease text
Print this page